Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
Hong Kong · Delayed Price · Currency is HKD 0.3550
0.00 (0.00%)
At close: Feb 13, 2026
HKG:0897 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -13.83 | 7.1 | -15.36 | -20.52 | -108.91 | -376 |
Depreciation & Amortization | 87.86 | 90.48 | 111.15 | 113.05 | 107.8 | 92.62 |
Loss (Gain) From Sale of Assets | -15.17 | -15.17 | -26.44 | 7.5 | -1.81 | 6.56 |
Asset Writedown & Restructuring Costs | -14.2 | -14.2 | 153.98 | 24.78 | 80.62 | 56.95 |
Loss (Gain) From Sale of Investments | 21.1 | 21.1 | 13.98 | 22.12 | 86.03 | 272.24 |
Loss (Gain) on Equity Investments | -1.05 | -1.05 | -2.53 | -2.95 | -1.57 | -4.65 |
Stock-Based Compensation | - | - | 3.84 | 4.65 | 1.14 | - |
Other Operating Activities | 12.85 | -13.36 | -31.51 | 61.49 | 65.5 | 65.13 |
Change in Accounts Receivable | -13.49 | -13.49 | -13.14 | -14 | -14.43 | 16.49 |
Change in Inventory | 65.7 | 65.7 | -45.96 | 94.91 | 303.02 | 126.07 |
Change in Accounts Payable | -4.94 | -4.94 | -2.29 | -3.14 | 12.21 | 1.68 |
Change in Unearned Revenue | -2.52 | -2.52 | -0.79 | -49 | -372.94 | 2.52 |
Change in Other Net Operating Assets | -17.33 | -17.33 | -24.8 | -64.51 | 12.45 | 152.93 |
Operating Cash Flow | 104.97 | 102.32 | 191.69 | 168.34 | 169.11 | 412.55 |
Operating Cash Flow Growth | -39.94% | -46.62% | 13.87% | -0.46% | -59.01% | - |
Capital Expenditures | -21.08 | -27.16 | -34.65 | -33.45 | -26.04 | -59.5 |
Sale of Property, Plant & Equipment | 19.31 | 62.07 | 86.82 | 2.6 | 0.88 | 4.25 |
Cash Acquisitions | - | - | -78.12 | - | - | - |
Divestitures | - | - | 165.02 | 46.65 | - | - |
Sale (Purchase) of Real Estate | -0.01 | 69.83 | -7.9 | 3.7 | -7.59 | -30.73 |
Investment in Securities | - | 42.06 | 69.26 | -3.38 | 20.23 | 8.14 |
Other Investing Activities | 46.22 | 49.08 | -183.34 | 1.3 | 22.37 | 17.3 |
Investing Cash Flow | 44.44 | 280.89 | -84.62 | 19.25 | 6.47 | -64.49 |
Long-Term Debt Issued | - | 60.08 | 818.97 | 952.2 | 589.87 | 426.36 |
Long-Term Debt Repaid | - | -233.7 | -1,117 | -1,004 | -679.51 | -692.85 |
Net Debt Issued (Repaid) | -102.37 | -173.62 | -297.69 | -51.99 | -89.64 | -266.48 |
Repurchase of Common Stock | - | -11.8 | -14.73 | -9.96 | - | - |
Common Dividends Paid | -0.3 | -199.14 | - | - | - | - |
Other Financing Activities | -22.12 | -21.13 | -157.55 | -96.96 | -114.78 | -84.39 |
Financing Cash Flow | -124.79 | -405.69 | -469.97 | -158.91 | -204.41 | -350.88 |
Foreign Exchange Rate Adjustments | 0.27 | -0.17 | -8.83 | -12.12 | 31.75 | 34.35 |
Net Cash Flow | 24.89 | -22.65 | -371.73 | 16.56 | 2.91 | 31.53 |
Free Cash Flow | 83.89 | 75.16 | 157.04 | 134.89 | 143.07 | 353.05 |
Free Cash Flow Growth | -45.95% | -52.14% | 16.42% | -5.72% | -59.48% | - |
Free Cash Flow Margin | 11.63% | 10.08% | 20.03% | 18.64% | 10.28% | 31.85% |
Free Cash Flow Per Share | 0.07 | 0.07 | 0.13 | 0.11 | 0.12 | 0.29 |
Cash Interest Paid | 22.16 | 25.51 | 139.82 | 86.35 | 58.46 | 84.39 |
Cash Income Tax Paid | 0.38 | 0.88 | 34.64 | 53.06 | 81.87 | 89.87 |
Levered Free Cash Flow | -6.8 | 147.82 | 733.16 | -5.57 | 22.41 | 313.76 |
Unlevered Free Cash Flow | 6.98 | 165.41 | 758.65 | 12.87 | 82.22 | 381.08 |
Change in Working Capital | 27.41 | 27.41 | -86.97 | -35.75 | -59.68 | 299.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.